학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 16건 | 목록 1~10
Academic Journal
de Jong J; a Janssen Research & Development , San Diego , CA , USA.; Skee D; b Janssen Research & Development , Raritan , NJ , USA.; Hellemans P; c Janssen Research & Development , Beerse , Belgium.; Jiao J; b Janssen Research & Development , Raritan , NJ , USA.; de Vries R; c Janssen Research & Development , Beerse , Belgium.; Swerts D; c Janssen Research & Development , Beerse , Belgium.; Lawitz E; d Texas Liver Institute, University of Texas Health Science Center San Antonio , TX , USA.; Marbury T; e Orlando Clinical Research Center , Orlando , FL , USA.; Smith W; f New Orleans Center for Clinical Research , Knoxville , TN , USA.; Sukbuntherng J; g Pharmacyclics LLC , Sunnyvale , CA , USA.; Mannaert E; c Janssen Research & Development , Beerse , Belgium.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Huang MQ; Janssen Research & Development, LLC, Pharmaceutical Companies of Johnson & Johnson, 1400 McKean Road, Spring House, PA 19477, USA. Electronic address: qingtao_huang@yahoo.com.; Kang L; Frontage Laboratories Inc., 700 Pennsylvania Drive, Exton, PA 19341, USA.; Wang W; Frontage Laboratories Inc., 700 Pennsylvania Drive, Exton, PA 19341, USA.; Skee D; Janssen Research & Development, LLC, Pharmaceutical Companies of Johnson & Johnson, 920 Rt 202, Raritan, NJ 08869, USA.; Chen M; Frontage Laboratories Inc., 700 Pennsylvania Drive, Exton, PA 19341, USA.; Lin ZJ; Frontage Laboratories Inc., 700 Pennsylvania Drive, Exton, PA 19341, USA.; Verhaeghe T; Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium.; Weng N; Janssen Research & Development, LLC, Pharmaceutical Companies of Johnson & Johnson, 1400 McKean Road, Spring House, PA 19477, USA.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-376X (Electronic) Linking ISSN: 15700232 NLM ISO Abbreviation: J Chromatogr B Analyt Technol Biomed Life Sci Subsets: MEDLINE
Academic Journal
de Vries R; Janssen Research & Development, Beerse, Belgium.; Smit JW; Janssen Research & Development, Beerse, Belgium.; Hellemans P; Janssen Research & Development, Beerse, Belgium.; Jiao J; Janssen Research & Development, Raritan, NJ, USA.; Murphy J; Janssen Research & Development, Raritan, NJ, USA.; Skee D; Janssen Research & Development, Raritan, NJ, USA.; Snoeys J; Janssen Research & Development, Beerse, Belgium.; Sukbuntherng J; Pharmacyclics, Inc., Sunnyvale, CA, USA.; Vliegen M; Janssen Research & Development, Beerse, Belgium.; de Zwart L; Janssen Research & Development, Beerse, Belgium.; Mannaert E; Janssen Research & Development, Beerse, Belgium.; de Jong J; Janssen Research & Development, San Diego, CA, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Academic Journal
de Jong J; Janssen Research & Development San Diego, California.; Skee D; Janssen Research & Development Raritan, New Jersey.; Murphy J; Janssen Research & Development Raritan, New Jersey.; Sukbuntherng J; Pharmacyclics Inc. Sunnyvale, California.; Hellemans P; Janssen Research & Development Beerse, Belgium.; Smit J; Janssen Research & Development Beerse, Belgium.; de Vries R; Janssen Research & Development Beerse, Belgium.; Jiao JJ; Janssen Research & Development Raritan, New Jersey.; Snoeys J; Janssen Research & Development Beerse, Belgium.; Mannaert E; Janssen Research & Development Beerse, Belgium.
Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2052-1707 (Print) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: PubMed not MEDLINE
Academic Journal
de Jong J; Janssen Research & Development, LLC, La Jolla, 3210 Merryfield Row, San Diego, CA, 92121, USA, jdejong1@its.jnj.com.; Sukbuntherng JSkee DMurphy JO'Brien SByrd JCJames DHellemans PLoury DJJiao JChauhan VMannaert E
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Devineni D; Janssen Research & Development, LLC, Raritan, NJ, USA.; Manitpisitkul P; Janssen Research & Development, LLC, Raritan, NJ, USA.; Murphy J; Janssen Research & Development, LLC, Raritan, NJ, USA.; Skee D; Janssen Research & Development, LLC, Raritan, NJ, USA.; Wajs E; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Mamidi RN; Janssen Research & Development, LLC, Raritan, NJ, USA.; Tian H; Janssen Research & Development, LLC, Raritan, NJ, USA.; Vandebosch A; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Wang SS; Janssen Research & Development, LLC, Raritan, NJ, USA.; Verhaeghe T; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Stieltjes H; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Usiskin K; Janssen Research & Development, LLC, Raritan, NJ, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Academic Journal
Scheers E; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Leclercq L; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; de Jong J; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Bode N; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Bockx M; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Laenen A; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Cuyckens F; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Skee D; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Murphy J; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Sukbuntherng J; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Mannens G; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.) gmannens@its.jnj.com.
Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE
Academic Journal
Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Skee D
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어